About Colin Foster
Colin Foster is a board member at NBO Pharma, which is testing nasal octreotide for idiopathic intracranial hypertension.
Experience
This experience comes from official bios, from Colin Foster's profile and from SEC filings. For roles taken from filings, the years are when the filings name Colin Foster in the role, so the role may have started earlier or lasted longer.
NBO Pharma Inc. Current
Board Member
2026 – Present · Bedford, NY
NBO is testing nasal octreotide as a treatment for idiopathic intracranial hypertension.
SI
Saatient Therapeutics Inc. Current
Chairman
2024 – Present
Cytosolix, Inc. Current
Chief Executive Officer and director
Executive Chairman (2023 – Present)
2023 – Present · Tolland, CT
CY
Columbia University in the City of New York Current
Senior Industry Advisor & Executive In Residence
2020 – Present
YU
Yale University Current
Entrepreneur in Residence
2018 – Present
NU
New York University Current
Industry Advisor, NYU Langone Health; Mentor, Endless Frontier Labs
2018 – Present
Ascendia Pharmaceuticals, Inc.
Board of Directors & Compensation Committee Member
2021 – 2023 · North Brunswick, NJ
Ascendia helps drug developers formulate, test, and manufacture difficult products from discovery through commercialization.
IL
iSci Management LLC
Chief Executive Officer
2011 – 2023
Oncosynergy, Inc.
Board of Directors & Chair, Finance & Business Operations Committee
2019 – 2022 · Stamford, CT
Develops experimental antibody treatments for people with cancer.
BI
Bioblast Pharma Ltd. (now Seelos Therapeutics, Inc.)
Chief Executive Officer, President & Board Member
2015 – 2017
OI
Optherion, Inc.
Co-founder, Chief Executive Officer, President & Board Member
2006 – 2016
II
Ivenix, Inc.
Executive Chairman
2014 – 2015
BA
Bayer AG
Chief Executive Officer & President, Bayer Pharmaceuticals Corp. & Regional Head, North America
1994 – 2004
NO
Novartis
Director of Marketing, Pharmaceutical Division
1988 – 1994
AI
A.H. Robins Canada, Inc.
Medical Sales Representative
1985 – 1986
Key Colleagues at Startups
The people Colin Foster works with at each company, as listed on that company's latest Form D.
NBO Pharma Inc. · Form D, Nov 9, 2026
FP
Fredric Price
Chairman & Chief Executive Officer
RF
Robert Friedman
Board Member
BG
Bard Geesaman
Board Member
Cytosolix, Inc. · Form D, Jun 28, 2023
Ascendia Pharmaceuticals, Inc. · Form D, Jul 13, 2022
Theron Odlaug
Director
RB
Robert Bloder
Chief Commercial Officer and director
JG
James Gale
Managing Director
JH
Jingjun Huang
CEO and director
Oncosynergy, Inc. · Form D/A, May 16, 2022
AS
Allen Salmasi
Director
Anne-Marie Carbonell
Founder, CEO & Chief Medical Officer, director
HP
Hen Park
Director